Mega Matrix Corp. Appoints Xiangchen (Steven) Gao as Chief Operating Officer
PALO ALTO, Calif., Jan. 19, 2024 (GLOBE NEWSWIRE) — Mega Matrix Corp. (“MPU” or the “Company”) (NYSE American: MPU), today […]
MangoRx’s Brand and Products to be Featured by Barstool Sports in Week of Programming Around the Biggest Sports Event of the Year on February 11
“King of the Internet” Dave Portnoy’s Uber-Popular Sports Media Company to Spotlight FDA-Approved Oral Testosterone Replacement ‘Prime’ by MangoRx, Powered […]
SOUTHERN CALIFORNIA BANCORP ANNOUNCES THE RETIREMENT OF CHAIRMAN EMERITUS AND DIRECTOR JOHN FARKASH
San Diego, Calif., Jan. 19, 2024 (GLOBE NEWSWIRE) — Southern California Bancorp (“us,” “we,” “our,” or the “Company”) (NASDAQ: BCAL), […]
NMI Holdings, Inc. Receives “A-” Insurer Financial Strength and “BBB+” Senior Debt Ratings from Fitch
EMERYVILLE, Calif., Jan. 19, 2024 (GLOBE NEWSWIRE) — NMI Holdings, Inc. (Nasdaq: NMIH) today announced that Fitch Ratings has assigned […]
MedBright AI to Present at CEM Bahamas Small-Cap Conference and Maxim Group’s 2024 Healthcare IT Conference
VANCOUVER, British Columbia, Jan. 19, 2024 (GLOBE NEWSWIRE) — MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7) […]
VERB’s MARKET.live Announces The Addition Of 5 More Trendsetting Retail Brands To Its Livestream Social Shopping Platform
LOS ALAMITOS, Calif. and LAS VEGAS, Jan. 19, 2024 (GLOBE NEWSWIRE) — Verb Technology Company, Inc. (Nasdaq: VERB) (“VERB” or […]
Phunware Announces Pricing of $5.6 Million Registered Direct Offering
AUSTIN, Texas, Jan. 19, 2024 (GLOBE NEWSWIRE) — Phunware, Inc. (Nasdaq: PHUN, “Phunware”), the pioneer of patented Location Based SaaS […]
TSX News -
Extendicare Announces Timing of 2023 Fourth Quarter Results and Conference Call
MARKHAM, Ontario, Jan. 19, 2024 (GLOBE NEWSWIRE) — Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it […]
Processa Pharmaceuticals Announces Expansion of NGC-Cap Program into Advanced or Metastatic Breast Cancer
FDA and Processa agree to expand NGC-Cap development into breast cancer providing a more efficient path to approval FDA agrees […]
Optimi Health Secures Amendment to Increase Quantities Of MDMA, MDA, And 2C-B Under Controlled Drugs And Substances Dealer’s Licence
VANCOUVER, British Columbia, Jan. 19, 2024 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or […]
